Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromultivit in Vertebrogenic Radiculopathy
NCT02508805Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- May 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thiamine + pyridoxine + cyanocobalamin in radiculopathy, sponsored by Valeant Pharmaceuticals. Started May 2015; status: completed.
02
Drugs
thiamine + pyridoxine + cyanocobalamin
03
Conditions
radiculopathy
Beyond the preview
Go deeper on NCT02508805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508805.